News und Analysen
Here's Why Novocure Stock Dropped 42% in June
Novocure (NASDAQ: NVCR) shares dropped after publishing the results of an important clinical trial. The headlines looked positive at first glance, but the study raised concerns that lung cancer
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Wall Street Thinks Viatris Stock Will Rise 25% -- Could It Grow Even More?
For a generic drugmaker like Viatris (NASDAQ: VTRS), big spurts of growth are unlikely. The market for low-cost generic medications is competitive, and success is largely defined by maintaining
EQS-News: Just – Evotec Biologics awarded second contract from U.S. Department of Defense under accelerated antibodies program
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Down 80% in 1 Day, Is There Any Hope for FibroGen Stock?
On June 26, FibroGen's (NASDAQ: FGEN) lead program, pamrevlumab, reported poor late-stage clinical trial results for the second time in a month, sending its stock barreling downward to the tune of
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme
Why Catalent Stock Flopped Today
It seems Catalent (NYSE: CTLT) was apparently the reason why a key drug was refused approval by the Food and Drug Administration (FDA).
According to a media report from a leading financial news
EQS-Adhoc: GN Store Nord A/S: GN announces divestment of BelAudição
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Nio Stock Raced Higher Today
From June 15 through Monday, shares of Nio (NYSE: NIO) ended each trading session lower than where they had finished the day before. On Tuesday, however, the China-based electric vehicle (EV) maker
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Shares of Abcam Are Jumping Friday
Shares of life sciences company Abcam (NASDAQ: ABCM) were up 13.7% Friday afternoon after rising more than 14.6% earlier in the day. The impetus for the rise was the company's board of directors
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec SE Annual General Meeting 2023 approves all proposed agenda items
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Shares of Schrödinger Rose This Week
Shares of Schrödinger (NASDAQ: SDGR) were up by 28.6% for the week on Friday morning after rising as high as 30.8%, according to data provided by S&P Global Market Intelligence. The drug discovery
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Bronson Behavioral Health Hospital Hosts Ribbon Cutting Ceremony
Bronson Behavioral Health Hospital (BBHH), located at the intersection of Glenn Cross Road and M-66 in Battle Creek, Michigan, held a ribbon cutting ceremony today to mark the completion of
